News Releases

- El nuevo análisis de la procalcitonina de Beckman Coulter ayuda al facultativo a determinar qué pacientes se encuentran en riesgo de evolucionar al estado de choque séptico El Access PCT...

Das umfangreichste Portfolio in der Branche für In-vitro-Diagnostiktests zur Erkennung und zum Management von Sepsis wird nun durch Access PCT verstärkt. BREA, Kalifornien, 26. März 2019...

Access PCT strengthens industry’s most extensive portfolio of in-vitro diagnostic testing for sepsis identification and management BREA, Calif. — (March 26, 2019) — Beckman Coulter, a global...

Beckman Coulter, a global leader in clinical diagnostics, announced today that its DxH 520 hematology analyzer has received 510(k) clearance from the U.S. Food and Drug Administration (FDA), and...

Le nouveau test a obtenu le marquage CE et une autorisation 501(k) de la FDA américaine BREA, Californie, 7 mars 2019 /PRNewswire/ -- Beckman Coulter, leader mondial dans le secteur du diagnostic...

Neuer Assay erhält CE-Kennzeichnung und U.S. FDA 501(k)-Zulassung BREA, Kalifornien, 7. März 2019 /PRNewswire/ -- Beckman Coulter, ein weltweit führender Anbieter in der klinischen Diagnostik,...

- El ensayo avanzado de HbA1c de Beckman Coulter permite a los médicos realizar un diagnóstico más preciso de pacientes con diabetes El nuevo ensayo obtiene la certificación de marcado CE y la...

Beckman Coulter, a global leader in the clinical diagnostics industry, today announced the latest addition to its comprehensive chemistry assay menu—the fully automated hemoglobin A1c (HbA1c)...

Beckman Coulter today announced the U.S. release of its DxONE Workflow Manager, the first and only cloud-based middleware offered by a major in-vitro diagnostics organization, designed to help...

Beckman Coulter, a global leader in the clinical diagnostics industry, today announced it is joining forces with Sepsis Alliance, the nation's leading sepsis organization, to support the Sepsis...